Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the IMPROVER Diagnostic Signature Challenge.
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Frequency analysis approach to study balance control in individuals with multiple sclerosis.
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Additive effect of prostaglandin E(2) and adenosine in mouse experimental autoimmune encephalomyelitis.
What place for {blacktriangledown}cannabis extract in MS?
Snake bite-induced leucoencephalopathy.
Vaccine against autoimmune disease: can helminths or their products provide a therapy?
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
The innate immune system in demyelinating disease.
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Microparticles: A New Perspective in Central Nervous System Disorders.
A 39 years old woman responding to modafinil with bilateral hypothalamic lesion associated with hyperthermia and hypersomnia: a case report.
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Pages
« first
‹ previous
…
463
464
465
466
467
468
469
470
471
…
next ›
last »